Most Recent
Money transfer biz directors slapped with first-ever sentences for cartel conduct
The directors of two money transfer businesses accused of fixing foreign exchange rates are the first ever individuals to be sentenced in Australia to prison terms for criminal cartel conduct.
ACCC may put brakes on Aurizon’s $2.3B bid for One Rail
The Australian Competition and Consumer Commission has raised preliminary concerns that Aurizon's proposed $2.3 billion acquisition of rail haulage company One Rail could stymie competition in the NSW and Queensland markets for coal haulage services by rail.
Meta wants details of tech capabilities kept under wraps in ACCC case
Facebook owner Meta is fighting for broad non-publication orders in its battle with the ACCC over material it says could prejudice jury members in criminal proceedings by mining magnate Andrew Forrest.
Airbnb taken to court for ‘misleading’ accommodation prices
Airbnb has been hit with legal action by the consumer watchdog alleging the prices shown on the vacation rental website differed from what consumers were charged.
ACCC, Fujifilm ‘close’ to settling case over small biz contracts
The Australian Competition and Consumer Commission is “close” to settling its case against office supply company Fujifilm over allegedly unfair contracts with small businesses, a court has heard.
Waste tyre boss owes $2M for using Maersk to take out his trash, shipper alleges
A judge has struck out a defence invoking the right against self-incrimination in a $2 million case brought by freight company Maersk alleging a Melbourne waste tyre company director used the shipper to dump end-of-life tyres overseas. 
Merricks Capital sues to stop former exec from working at Switzer-led boutique
Melbourne-based hard assets investment manager Merricks Capital has filed court proceedings to block its ex-managing director and two other former employees from working at a investment boutique run by financial commentator Peter Switzer and his son Marty.
Mesoblast hit with second shareholder class action over COVID-19 drug
Regenerative medicine company Mesoblast has been hit with a second class action for allegedly misleading shareholders about it Remestemcel-L treatment for COVID-19 complications.
Nuix says ex-CEO’s claim off by $140M, but Macquarie director must front court to explain
A former Nuix director appointed by Macquarie Bank must give evidence in person as the embattled tech company argues a claim brought by its former CEO is off by $140 million.
Justice is colour-blind: Loss for Nick Scali not indictment on white furniture, says VCAT
Nick Scali has been ordered to refund a disgruntled customer $1,600 for a white leather chair that discoloured mere months after use.